vTv Therapeutics Inc. Class A Common Stock

VTVTNASDAQ • USD
18.23 USD
↘ 1.46 (7.41%)🟢LIVE (AS OF 12:36 PM EST)
🟢Market: OPEN

vTv Therapeutics Inc. Class A Common Stock (VTVT) is currently trading at $18.23. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, VTVT appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$19.41
High?$19.72
Low?$17.53
Prev. Close?$19.69
Volume?10.7K
Avg. Volume?22.8K
VWAP?$18.12
Rel. Volume?0.47x
Bid / Ask
Bid?$15.17 × 100
Ask?$20.79 × 100
Spread?$5.62
Midpoint?$17.98
Valuation & Ratios
Market Cap?79.0M
Shares Out?4.0M
Float?1.5M
Float %?37.6%
P/E Ratio?N/A
P/B Ratio?1.13
EPS?-$1.91
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.
Employees
26
Market Cap
79.0M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2015-07-30
Address
3980 PREMIER DR
HIGH POINT, NC 27265
Phone: 336-841-0300
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
6
Momentum?
65
Short Sent.?
54
Piotroski F-Score?0/9Weak
Altman Z-Score?0.58Distress
Confidence?50%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?9.82%Elevated
Short Interest?145.4K
Days to Cover?8.2
Free Float1.5M
Avg Daily Volume17.7K
Settlement Date2026-10-30
Financial Health
Current Ratio?11.19Strong
Quick Ratio?11.19Strong
Cash Ratio?10.99Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
94
1.13CHEAP▾
P/S?
Peers
100
S&P
63
2.14CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.2CHEAP▾
EV/Sales?
Peers
100
S&P
97
0.05CHEAP▾
Returns & Efficiency
ROE?
S&P
9
-11.0%WEAK▾
ROA?
S&P
3
-9.8%WEAK▾
Cash Flow & Enterprise
FCF?$-21728000
Enterprise Value?$1.8M
Fundamentals ratios updated end of day